semaphorin 4A
Showing 1 - 25 of >10,000
Inflammatory Disease in Multiple Sclerosis
Active, not recruiting
- Relapsing Multiple Sclerosis
- Multiple Sclerosis
- Cerebrospinal and Blood Serum Semaphorin 4A Levels
-
Portland, OregonProvidence St. Vincent Medical Center
May 19, 2022
Gingivitis, Periodontitis, Periodontal Diseases Trial in Izmir (Non-surgical Periodontal Treatment)
Completed
- Gingivitis
- +2 more
- Non-surgical Periodontal Treatment
-
Izmir, Cigli, TurkeyIzmir Katip Celebi University, Faculty of Dentistry
Feb 9, 2021
Relaxin in Multiple Sclerosis (MS)
Recruiting
- Multiple Sclerosis, Relapsing-Remitting
- Blood Draw
- Lumbar Puncture
-
Portland, OregonProvidence MS Center
Feb 2, 2022
Keloid, Wound Heal, Wound Trial in Singapore (siSPARC + siLR4A microneedle patches, siSPARC microneedle patch)
Recruiting
- Keloid
- +2 more
- siSPARC + siLR4A microneedle patches
- siSPARC microneedle patch
-
Singapore, SingaporeNational Skin Centre
Nov 17, 2023
Epidural Analgesia on Labour, Neonatal and Maternal Outcomes.
Completed
- Labor Pain
- +2 more
- Epidural Analgesia
-
Rome, ItalyIRCCS Policlinico Agostino Gemelli
Oct 11, 2022
Epidemic Meningitis Trial (MCV4, MSPV4)
Not yet recruiting
- Epidemic Meningitis
- MCV4
- MSPV4
- (no location specified)
Aug 21, 2023
Behçet's Disease Trial in Beijing (Hemay005, Placebo)
Recruiting
- Behçet's Disease
- Hemay005
- Placebo
-
Beijing, Beijing, ChinaPeking University People's Hospital
Nov 17, 2023
Healthy Trial in London (NTP42:KVA4 Capsule, NTP42:KVA4 Liquid)
Recruiting
- Healthy
- NTP42:KVA4 Capsule
- NTP42:KVA4 Liquid
-
London, United KingdomHammersmith Medicines Research
Oct 20, 2023
Mental Health Issue, Mental Health Wellness 1 Trial in London (MeT4VeT mobile phone app: control, MeT4VeT mobile phone app:
Completed
- Mental Health Issue
- Mental Health Wellness 1
- MeT4VeT mobile phone app: control
- MeT4VeT mobile phone app: intervention
-
London, United KingdomKing's College London
Aug 8, 2023
Sensorineural Hearing Loss, Bilateral, Bilateral Hearing Loss Trial in Saint-Étienne (FS4 then TFS4 (cochlear implant), TFS4
Not yet recruiting
- Sensorineural Hearing Loss, Bilateral
- Bilateral Hearing Loss
- FS4 then TFS4 (cochlear implant)
- TFS4 then FS4 (cochlear implant)
-
Saint-Étienne, FranceCHU Saint-Etienne
Jul 13, 2023
Pregnancy Related, Adolescent Behavior, Sexually Transmitted Diseases Trial in Berkeley (Next4You)
Enrolling by invitation
- Pregnancy Related
- +2 more
- Next4You
-
Berkeley, CaliforniaRTI
Nov 7, 2023
Bladder Cancer Trial (Multi4)
Not yet recruiting
- Bladder Cancer
- Multi4
- (no location specified)
Nov 14, 2023
Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)
Not yet recruiting
- Diabetes Mellitus Type 2 With Proteinuria
- +12 more
- Empagliflozin 10 MG
- +6 more
- (no location specified)
Oct 17, 2023
Clinical Phenotypic Characteristics of SC26A4
Recruiting
- Hearing Loss
- Pendred Syndrome
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Jul 24, 2023
Facio-Scapulo-Humeral Dystrophy Trial (ARO-DUX4 for Injection, Placebo)
Not yet recruiting
- Facio-Scapulo-Humeral Dystrophy
- ARO-DUX4 for Injection
- Placebo
- (no location specified)
Nov 13, 2023
Nursing Students Trial (4-7-8 Breathing Exercise Training)
Not yet recruiting
- Nursing Students
- 4-7-8 Breathing Exercise Training
- (no location specified)
Oct 27, 2023
Healthy Trial in Basel (MDMA 120 mg + MDMA 60 mg, MDMA 120 mg + , Placebo)
Not yet recruiting
- Healthy
- MDMA 120 mg + MDMA 60 mg
- +2 more
-
Basel, SwitzerlandUniversity Hospital
Mar 28, 2023
Bone Metastases Trial (4 Herbs Formula)
Not yet recruiting
- Bone Metastases
- 4 Herbs Formula
- (no location specified)
Sep 4, 2023
Lymphoma Trial (Ultra Low Dose 4 Gy Radiation)
Not yet recruiting
- Lymphoma
- Ultra Low Dose 4 Gy Radiation
- (no location specified)
Jun 30, 2023
Wilson's Disease Trial in London (900mg TETA 4HCl Once Daily Formulation, 900mg TETA 4HCl Cuprior®)
Not yet recruiting
- Wilson's Disease
- 900mg TETA 4HCl Once Daily Formulation
- 900mg TETA 4HCl Cuprior®
-
London, United KingdomRichmond Pharmacology Ltd
Nov 7, 2023
Ovarian Cancer Trial (Autologous genetically modified ADP-A2M4CD8 cells, Autologous genetically modified ADP-A2M4CD8 cells in
Not yet recruiting
- Ovarian Cancer
- Autologous genetically modified ADP-A2M4CD8 cells
- Autologous genetically modified ADP-A2M4CD8 cells in combination with Nivolumab
- (no location specified)
Jan 31, 2023
CYP3A4*22 Trial (Palbociclib 125Mg Tab, Ribociclib 200Mg Oral Tablet, Abemaciclib 150 MG Oral Tablet)
Not yet recruiting
- CYP3A4*22
- Palbociclib 125Mg Tab
- +2 more
- (no location specified)
Jan 10, 2023
Prostate Cancer Trial ([99mTc]Tc-PSMA-T4)
Not yet recruiting
- Prostate Cancer
- [99mTc]Tc-PSMA-T4
- (no location specified)
Apr 26, 2023
Autoimmune Diseases Trial in Beijing (, mycophenolate mofetil)
Not yet recruiting
- Autoimmune Diseases
- placebo
- mycophenolate mofetil
-
Beijing, ChinaPeking Union Medical College Hospital
Jul 26, 2023
PCR Based CEUS in BI RADS 4A Nodules
Active, not recruiting
- PCA
- Breast Cancer
- imaging
-
Hanzhou, Zhejiang, ChinaSAHZJU
Jul 13, 2021